Nina Wettschureck and Stefan Offermanns - Physiological Reviews

More documents

Recommendations

Info

1196 NINA WETTSCHURECK AND STEFAN OFFERMANNS 411. Majumdar M, Seasholtz TM, Buckmaster C, Toksoz D, and Brown JH. A rho exchange factor mediates thrombin and Galpha(12)-induced cytoskeletal responses. J Biol Chem 274: 26815– 26821, 1999. 412. Malbon CC. Insulin signalling: putting the ’G-’ in protein-protein interactions. Biochem J 380: 11–12, 2004. 413. Manning DR. Evidence mounts for receptor-independent activation of heterotrimeric G proteins normally in vivo: positioning of the mitotic spindle in C. elegans. Sci STKE 2003: pe35, 2003. 414. Mantovani G, Ballare E, Giammona E, Beck-Peccoz P, and Spada A. The Gsalpha gene: predominant maternal origin of transcription in human thyroid gland and gonads. J Clin Endocrinol Metab 87: 4736–4740, 2002. 415. Mantovani G, Maghnie M, Weber G, De Menis E, Brunelli V, Cappa M, Loli P, Beck-Peccoz P, and Spada A. Growth hormone-releasing hormone resistance in pseudohypoparathyroidism type Ia: new evidence for imprinting of the Gs alpha gene. J Clin Endocrinol Metab 88: 4070–4074, 2003. 416. Margolskee RF. Molecular mechanisms of bitter and sweet taste transduction. J Biol Chem 277: 1–4, 2002. 417. Marians RC, Ng L, Blair HC, Unger P, Graves PN, and Davies TF. Defining thyrotropin-dependent and -independent steps of thyroid hormone synthesis by using thyrotropin receptor-null mice. Proc Natl Acad Sci USA 99: 15776–15781, 2002. 418. Marie JC, Rosselin G, and Skoglund G. Pancreatic beta-cell receptors and G proteins coupled to adenylyl cyclase. Ann NY Acad Sci 805: 122–132, 1996. 419. Marinaro M, Staats HF, Hiroi T, Jackson RJ, Coste M, Boyaka PN, Okahashi N, Yamamoto M, Kiyono H, Bluethmann H, Fujihashi K, and McGhee JR. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. J Immunol 155: 4621–4629, 1995. 420. Mark MD and Herlitze S. G protein mediated gating of inwardrectifier K � channels. Eur J Biochem 267: 5830–5836, 2000. 421. Marsh KA and Hill SJ. Bradykinin B2 receptor-mediated phosphoinositide hydrolysis in bovine cultured tracheal smooth muscle cells. Br J Pharmacol 107: 443–447, 1992. 422. Marteau F, Le Poul E, Communi D, Labouret C, Savi P, Boeynaems JM, and Gonzalez NS. Pharmacological characterization of the human P2Y13 receptor. Mol Pharmacol 64: 104–112, 2003. 423. Maruyama Y, Nishida M, Sugimoto Y, Tanabe S, Turner JH, Kozasa T, Wada T, Nagao T, and Kurose H. Galpha(12/13) mediates alpha(1)-adrenergic receptor-induced cardiac hypertrophy. Circ Res 91: 961–969, 2002. 424. Mastorakos G, Mitsiades NS, Doufas AG, and Koutras DA. Hyperthyroidism in McCune-Albright syndrome with a review of thyroid abnormalities sixty years after the first report. Thyroid 7: 433–439, 1997. 425. Masu M, Iwakabe H, Tagawa Y, Miyoshi T, Yamashita M, Fukuda Y, Sasaki H, Hiroi K, Nakamura Y, and Shigemoto R. Specific deficit of the ON response in visual transmission by targeted disruption of the mGluR6 gene. Cell 80: 757–765, 1995. 426. Masumoto A, Hirooka Y, Shimokawa H, Hironaga K, Setoguchi S, and Takeshita A. Possible involvement of Rho-kinase in the pathogenesis of hypertension in humans. Hypertension 38: 1307– 1310, 2001. 427. Matsumoto K, Fukunaga K, Miyazaki J, Shichiri M, and Miyamoto E. Ca 2� /calmodulin-dependent protein kinase II and synapsin I-like protein in mouse insulinoma MIN6 cells. Endocrinology 136: 3784–3793, 1995. 428. Matsunami H and Buck LB. A multigene family encoding a diverse array of putative pheromone receptors in mammals. Cell 90: 775–784, 1997. 429. Matsunami H, Montmayeur JP, and Buck LB. A family of candidate taste receptors in human and mouse. Nature 404: 601–604, 2000. 430. Mayo KE, Godfrey PA, Suhr ST, Kulik DJ, and Rahal JO. Growth hormone-releasing hormone: synthesis and signaling. Recent Prog Horm Res 50: 35–73, 1995. 431. Mayo KE, Miller LJ, Bataille D, Dalle S, Goke B, Thorens B, and Drucker DJ. International Union of Pharmacology. XXXV. The glucagon receptor family. Pharmacol Rev 55: 167–194, 2003. Physiol Rev • VOL 85 • OCTOBER 2005 • www.prv.org 432. Mehlmann LM, Jones TL, and Jaffe LA. Meiotic arrest in the mouse follicle maintained by a G s protein in the oocyte. Science 297: 1343–1345, 2002. 433. Mehlmann LM, Saeki Y, Tanaka S, Brennan TJ, Evsikov AV, Pendola FL, Knowles BB, Eppig JJ, and Jaffe LA. The G slinked receptor GPR3 maintains meiotic arrest in mammalian oocytes. Science 306: 1947–1950, 2004. 434. Meigs TE, Fedor-Chaiken M, Kaplan DD, Brackenbury R, and Casey PJ. Galpha12 and Galpha13 negatively regulate the adhesive functions of cadherin. J Biol Chem 277: 24594–24600, 2002. 435. Meigs TE, Fields TA, McKee DD, and Casey PJ. Interaction of Galpha 12 and Galpha 13 with the cytoplasmic domain of cadherin provides a mechanism for beta-catenin release. Proc Natl Acad Sci USA 98: 519–524, 2001. 436. Melyan Z, Tarttelin EE, Bellingham J, Lucas RJ, and Hankins MW. Addition of human melanopsin renders mammalian cells photoresponsive. Nature 433: 741–745, 2005. 437. Mende U, Kagen A, Cohen A, Aramburu J, Schoen FJ, and Neer EJ. Transient cardiac expression of constitutively active Galphaq leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways. Proc Natl Acad Sci USA 95: 13893–13898, 1998. 438. Meng J and Casey PJ. Signaling through Gz. In: Handbook of Cell Signaling, edited by Bradshaw RA and Dennis EA. Boston, MA: Academic, 2004, p. 601–604. 439. Meza U and Adams B. G protein-dependent facilitation of neuronal alpha1A, alpha1B, and alpha1E Ca channels. J Neurosci 18: 5240–5252, 1998. 440. Michel MC, Beck-Sickinger A, Cox H, Doods HN, Herzog H, Larhammar D, Quirion R, Schwartz T, and Westfall TX VI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev 50: 143–150, 1998. 441. Michoud MC, Tolloczko B, and Martin JG. Effects of purine nucleotides and nucleoside on cytosolic calcium levels in rat tracheal smooth muscle cells. Am J Respir Cell Mol Biol 16: 199–205, 1997. 442. Mieda M and Yanagisawa M. Sleep, feeding, and neuropeptides: roles of orexins and orexin receptors. Curr Opin Neurobiol 12: 339–345, 2002. 443. Milano CA, Allen LF, Rockman HA, Dolber PC, McMinn TR, Chien KR, Johnson TD, Bond RA, and Lefkowitz RJ. Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor. Science 264: 582–586, 1994. 444. Milano CA, Dolber PC, Rockman HA, Bond RA, Venable ME, Allen LF, and Lefkowitz RJ. Myocardial expression of a constitutively active alpha 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy. Proc Natl Acad Sci USA 91: 10109– 10113, 1994. 445. Millar RP, Lu ZL, Pawson AJ, Flanagan CA, Morgan K, and Maudsley SR. Gonadotropin-releasing hormone receptors. Endocr Rev 25: 235–275, 2004. 446. Miller MJ, Rioux L, Prendergast GV, Cannon S, White MA, and Meinkoth JL. Differential effects of protein kinase A on Ras effector pathways. Mol Cell Biol 18: 3718–3726, 1998. 447. Miller RE. Pancreatic neuroendocrinology: peripheral neural mechanisms in the regulation of the Islets of Langerhans. Endocr Rev 2: 471–494, 1981. 448. Milligan G and Grassie MA. How do G proteins stay at the plasma membrane? Essays Biochem 32: 49–60, 1997. 449. Mirotznik RR, Zheng X, and Stanley EF. G protein types involved in calcium channel inhibition at a presynaptic nerve terminal. J Neurosci 20: 7614–7621, 2000. 450. Missy K, Plantavid M, Pacaud P, Viala C, Chap H, and Payrastre B. Rho-kinase is involved in the sustained phosphorylation of myosin and the irreversible platelet aggregation induced by PAR1 activating peptide. Thromb Haemost 85: 514–520, 2001. 451. Miura M, Watanabe M, Offermanns S, Simon MI, and Kano M. Group I metabotropic glutamate receptor signaling via Galpha q/Galpha 11 secures the induction of long-term potentiation in the hippocampal area CA1. J Neurosci 22: 8379–8390, 2002. 452. Miyata M, Finch EA, Khiroug L, Hashimoto K, Hayasaka S, Oda SI, Inouye M, Takagishi Y, Augustine GJ, and Kano M.
Local calcium release in dendritic spines required for long-term synaptic depression. Neuron 28: 233–244, 2000. 453. Miyata M, Kim HT, Hashimoto K, Lee TK, Cho SY, Jiang H, Wu Y, Jun K, Wu D, Kano M, and Shin HS. Deficient long-term synaptic depression in the rostral cerebellum correlated with impaired motor learning in phospholipase C beta4 mutant mice. Eur J Neurosci 13: 1945–1954, 2001. 454. Mochly-Rosen D, Wu G, Hahn H, Osinska H, Liron T, Lorenz JN, Yatani A, Robbins J, and Dorn GW II. Cardiotrophic effects of protein kinase C epsilon: analysis by in vivo modulation of PKCepsilon translocation. Circ Res 86: 1173–1179, 2000. 455. Moers A, Nieswandt B, Massberg S, Wettschureck N, Gruner S, Konrad I, Schulte V, Aktas B, Gratacap MP, Simon MI, Gawaz M, and Offermanns S. G13 is an essential mediator of platelet activation in hemostasis and thrombosis. Nat Med 9: 1418– 1422, 2003. 456. Moers A, Wettschureck N, Gruner S, Nieswandt B, and Offermanns S. Unresponsiveness of platelets lacking both G�q and G�13: implications for collagen-induced platelet activation. J Biol Chem 279: 45354–45359, 2004. 457. Mombaerts P. Genes and ligands for odorant, vomeronasal and taste receptors. Nat Rev Neurosci 5: 263–278, 2004. 458. Montaner S, Sodhi A, Molinolo A, Bugge TH, Sawai ET, He Y, Li Y, Ray PE, and Gutkind JS. Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi’s sarcomagenesis and can promote the tumorigenic potential of viral latent genes. Cancer Cell 3: 23–36, 2003. 459. Moxham CM, Hod Y, and Malbon CC. Gi alpha 2 mediates the inhibitory regulation of adenylylcyclase in vivo: analysis in transgenic mice with Gi alpha 2 suppressed by inducible antisense RNA. Dev Genet 14: 266–273, 1993. 460. Moxham CM, Hod Y, and Malbon CC. Induction of G alpha i2-specific antisense RNA in vivo inhibits neonatal growth. Science 260: 991–995, 1993. 461. Moxham CM and Malbon CC. Insulin action impaired by deficiency of the G protein subunit G ialpha2. Nature 379: 840–844, 1996. 462. Muca C and Vallar L. Expression of mutationally activated G alpha s stimulates growth and differentiation of thyroid FRTL5 cells. Oncogene 9: 3647–3653, 1994. 463. Mueller KL, Hoon MA, Erlenbach I, Chandrashekar J, Zuker CS, and Ryba NJ. The receptors and coding logic for bitter taste. Nature 434: 225–229, 2005. 464. Munoz JJ and Mackay IR. Production of experimental allergic encephalomyelitis with the aid of pertussigen in mouse strains considered genetically resistant. J Neuroimmunol 7: 91–96, 1984. 465. Murakami N, Yokomizo T, Okuno T, and Shimizu T. G2A is a proton-sensing G protein-coupled receptor antagonized by lysophosphatidylcholine. J Biol Chem 279: 42484–42491, 2004. 466. Murphy PM. International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature. Pharmacol Rev 54: 227–229, 2002. 467. Murphy PM, Baggiolini M, Charo IF, Hebert CA, Horuk R, Matsushima K, Miller LH, Oppenheim JJ, and Power CA. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 52: 145–176, 2000. 468. Nagata K, Ye C, Jain M, Milstone DS, Liao R, and Mortensen RM. Galpha(i2) but not Galpha(i3) is required for muscarinic inhibition of contractility and calcium currents in adult cardiomyocytes. Circ Res 87: 903–909, 2000. 469. Nakano K, Suga S, Takeo T, Ogawa Y, Suda T, Kanno T, and Wakui M. Intracellular Ca(2�) modulation of ATP-sensitive K(�) channel activity in acetylcholine-induced activation of rat pancreatic beta-cells. Endocrinology 143: 569–576, 2002. 470. Narumiya S, Sugimoto Y, and Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 79: 1193–1226, 1999. 471. Nathans J. The evolution and physiology of human color vision: insights from molecular genetic studies of visual pigments. Neuron 24: 299–312, 1999. 472. Navarro VM, Castellano JM, Fernandez-Fernandez R, Barreiro ML, Roa J, Sanchez-Criado JE, Aguilar E, Dieguez C, Pinilla L, and Tena-Sempere M. Developmental and hormonally CELLULAR FUNCTIONS OF G PROTEINS 1197 Physiol Rev • VOL 85 • OCTOBER 2005 • www.prv.org regulated messenger ribonucleic acid expression of KiSS-1 and its putative receptor, GPR54, in rat hypothalamus and potent luteinizing hormone-releasing activity of KiSS-1 peptide. Endocrinology 145: 4565–4574, 2004. 473. Nebigil CG, Choi DS, Dierich A, Hickel P, Le Meur M, Messaddeq N, Launay JM, and Maroteaux L. Serotonin 2B receptor is required for heart development. Proc Natl Acad Sci USA 97: 9508–9513, 2000. 474. Nebigil CG, Jaffre F, Messaddeq N, Hickel P, Monassier L, Launay JM, and Maroteaux L. Overexpression of the serotonin 5-HT 2B receptor in heart leads to abnormal mitochondrial function and cardiac hypertrophy. Circulation 107: 3223–3229, 2003. 475. Neer EJ. Heterotrimeric G proteins: organizers of transmembrane signals. Cell 80: 249–257, 1995. 476. Nel AE, Vandenplas M, Wooten MM, Cooper R, Vandenplas S, Rheeder A, and Daniels J. Cholera toxin partially inhibits the T-cell response to phytohaemagglutinin through the ADP-ribosylation of a 45 kDa membrane protein. Biochem J 256: 383–390, 1988. 477. Nelson G, Hoon MA, Chandrashekar J, Zhang Y, Ryba NJ, and Zuker CS. Mammalian sweet taste receptors. Cell 106: 381–390, 2001. 478. Nemeth EF and Scarpa A. Rapid mobilization of cellular Ca 2� in bovine parathyroid cells evoked by extracellular divalent cations. Evidence for a cell surface calcium receptor. J Biol Chem 262: 5188–5196, 1987. 479. Neptune ER and Bourne HR. Receptors induce chemotaxis by releasing the betagamma subunit of Gi, not by activating Gq or Gs. Proc Natl Acad Sci USA 94: 14489–14494, 1997. 480. Neptune ER, Iiri T, and Bourne HR. Galphai is not required for chemotaxis mediated by Gi-coupled receptors. J Biol Chem 274: 2824–2828, 1999. 481. Neubig RR and Siderovski DP. Regulators of G protein signalling as new central nervous system drug targets. Nat Rev Drug Discov 1: 187–197, 2002. 482. Neumann J, Schmitz W, Scholz H, von Meyerinck L, Doring V, and Kalmar P. Increase in myocardial Gi-proteins in heart failure. Lancet 2: 936–937, 1988. 483. Nieswandt B, Schulte V, Zywietz A, Gratacap MP, and Offermanns S. Costimulation of Gi- and G12/G13-mediated signaling pathways induces integrin alpha IIbbeta 3 activation in platelets. J Biol Chem 277: 39493–39498, 2002. 484. Niggli V. Signaling to migration in neutrophils: importance of localized pathways. Int J Biochem Cell Biol 35: 1619–1638, 2003. 485. Niu J, Vaiskunaite R, Suzuki N, Kozasa T, Carr DW, Dulin N, and Voyno-Yasenetskaya TA. Interaction of heterotrimeric G13 protein with an A-kinase-anchoring protein 110 (AKAP110) mediates cAMP-independent PKA activation. Curr Biol 11: 1686–1690, 2001. 486. Norlin EM, Gussing F, and Berghard A. Vomeronasal phenotype and behavioral alterations in G alpha i2 mutant mice. Curr Biol 13: 1214–1219, 2003. 487. Oak JN and Van Tol Dopamine HHM. Dopamine system. In: Encyclopedic Reference of Molecular Pharmacology, edited by Offermanns S and Rosenthal W. Berlin: Springer, 2004, p. 310–315. 488. Ofer W. G protein regulation of channels. In: Handbook of Cell Signaling, edited by Bradshaw RA and Dennis EA. Boston, MA: Academic Press, 2004, p. 667–670. 489. Offermanns S, Hashimoto K, Watanabe M, Sun W, Kurihara H, Thompson RF, Inoue Y, Kano M, and Simon MI. Impaired motor coordination and persistent multiple climbing fiber innervation of cerebellar Purkinje cells in mice lacking Galphaq. Proc Natl Acad Sci USA 94: 14089–14094, 1997. 490. Offermanns S, Heiler E, Spicher K, and Schultz G. Gq and G11 are concurrently activated by bombesin and vasopressin in Swiss 3T3 cells. FEBS Lett 349: 201–204, 1994. 491. Offermanns S, Hu YH, and Simon MI. Galpha12 and Galpha13 are phosphorylated during platelet activation. J Biol Chem 271: 26044–26048, 1996. 492. Offermanns S, Laugwitz KL, Spicher K, and Schultz G. G proteins of the G12 family are activated via thromboxane A 2 and thrombin receptors in human platelets. Proc Natl Acad Sci USA 91: 504–508, 1994.
Page 1 and 2: Mammalian G Proteins and Their Cell
Page 3 and 4: TABLE 1. Physiological ligands of G
Page 5 and 6: TABLE 1—Continued Sensory Stimuli
Page 7 and 8: FIG. 1. Functional cycle of G prote
Page 9 and 10: promoter driving the expression of
Page 11 and 12: FIG. 5.G q/G 11 family G proteins a
Page 13 and 14: G proteins, which mediate bronchoco
Page 15 and 16: lets under physiological and pathol
Page 17 and 18: to mediate these effects. The forme
Page 19 and 20: e attributed to an impaired lipolyt
Page 21 and 22: kocytes (56). Indirect evidence for
Page 23 and 24: A. Visual System The human retina c
Page 25 and 26: addressed the role of G proteins in
Page 27 and 28: C. G i-Mediated Cell Transformation
Page 29 and 30: 45. Berstein G, Blank JL, Jhon DY,
Page 31 and 32: 123. Cyster JG. Chemokines, sphingo
Page 33 and 34: 207. Gehrmann J, Meister M, Maguire
Page 35 and 36: 290. Imamura T, Vollenweider P, Ega
Page 37: 369. Laurent E, Mockel J, Van Sande
Page 41 and 42: 533. Radu CG, Yang LV, Riedinger M,
Page 43 and 44: 616. Suwazono Y, Okubo Y, Kobayashi
Page 45 and 46: 695. Wu D, Huang CK, and Jiang H. R

Nina Wettschureck and Stefan Offermanns - Physiological Reviews

Create successful ePaper yourself

Delete template?

Save as template?